These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

66 related items for PubMed ID: 9513723

  • 21. Expression of epidermal growth factor receptor or ErbB3 facilitates geldanamycin-induced down-regulation of ErbB2.
    Pedersen NM, Breen K, Rødland MS, Haslekås C, Stang E, Madshus IH.
    Mol Cancer Res; 2009 Feb; 7(2):275-84. PubMed ID: 19208749
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. A dimerization hierarchy in the transmembrane domains of the HER receptor family.
    Duneau JP, Vegh AP, Sturgis JN.
    Biochemistry; 2007 Feb 20; 46(7):2010-9. PubMed ID: 17253768
    [Abstract] [Full Text] [Related]

  • 25. c-erbB-2 and human cancer.
    Pastan I.
    Jpn J Cancer Res; 1993 Oct 20; 84(10):inside front cover. PubMed ID: 7901189
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Selective formation of ErbB-2/ErbB-3 heterodimers depends on the ErbB-3 affinity of epidermal growth factor-like ligands.
    Stortelers C, van der Woning SP, Jacobs-Oomen S, Wingens M, van Zoelen EJ.
    J Biol Chem; 2003 Apr 04; 278(14):12055-63. PubMed ID: 12556529
    [Abstract] [Full Text] [Related]

  • 28. Ready to partner.
    Sliwkowski MX.
    Nat Struct Biol; 2003 Mar 04; 10(3):158-9. PubMed ID: 12605220
    [No Abstract] [Full Text] [Related]

  • 29. Investigation of the dimerization of proteins from the epidermal growth factor receptor family by single wavelength fluorescence cross-correlation spectroscopy.
    Liu P, Sudhaharan T, Koh RM, Hwang LC, Ahmed S, Maruyama IN, Wohland T.
    Biophys J; 2007 Jul 15; 93(2):684-98. PubMed ID: 17468161
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Clinical pharmacogenetics in oncology: the paradigm of molecular targeted therapies.
    Mountzios G, Sanoudou D, Syrigos KN.
    Curr Pharm Des; 2010 Jul 15; 16(20):2184-93. PubMed ID: 20459386
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Therapeutic targeting of the phosphatidylinositol 3-kinase signaling pathway: novel targeted therapies and advances in the treatment of colorectal cancer.
    Yu M, Grady WM.
    Therap Adv Gastroenterol; 2012 Sep 15; 5(5):319-37. PubMed ID: 22973417
    [Abstract] [Full Text] [Related]

  • 37. Wa5 is a novel ENU-induced antimorphic allele of the epidermal growth factor receptor.
    Lee D, Cross SH, Strunk KE, Morgan JE, Bailey CL, Jackson IJ, Threadgill DW.
    Mamm Genome; 2004 Jul 15; 15(7):525-36. PubMed ID: 15366372
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Evidence for the differential expression of a variant EGF receptor protein in human prostate cancer.
    Olapade-Olaopa EO, Moscatello DK, MacKay EH, Horsburgh T, Sandhu DP, Terry TR, Wong AJ, Habib FK.
    Br J Cancer; 2000 Jan 15; 82(1):186-94. PubMed ID: 10638988
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.